School of Environment and Science, Griffith University, Gold Coast, QLD 4222, Australia.
Department of Chemistry, Faculty of Science, Prince of Songkla University, Hat Yai, Songkhla 90112, Thailand.
Mar Drugs. 2021 Feb 7;19(2):95. doi: 10.3390/md19020095.
Two new fluorescent pteridine alkaloids, tedaniophorbasins A () and B (), together with the known alkaloid -methyltryptamine, were isolated, through application of mass directed purification, from the sponge collected from northern New South Wales, Australia. The structures of tedaniophorbasins A and B were deduced from the analysis of 1D/2D NMR and MS data and through application of C NMR DFT calculations. Tedaniophorbasin A possesses a novel 2-imino-1,3-dimethyl-2,3,7,8-tetrahydro-1H-[1,4]thiazino[3,2-g]pteridin-4(6)-one skeleton, while tedaniophorbasin B is its 2-oxo derivative. The compounds show significant Stokes shifts (~14,000 cm) between excitation and emission wavelengths in their fluorescence spectra. The new compounds were tested for bioactivity against chloroquine-sensitive and chloroquine-resistant strains of the malaria parasite , breast and pancreatic cancer cell lines, and the protozoan parasite but were inactive against all targets at 40 µM.
从澳大利亚新南威尔士州北部采集的海绵中,通过应用质量导向的纯化方法,分离得到了两个新的荧光蝶啶生物碱,即 tedaniophorbasin A()和 B(),以及已知的生物碱 -methyltryptamine。通过对 1D/2D NMR 和 MS 数据的分析以及通过应用 C NMR DFT 计算,推断出 tedaniophorbasin A 和 B 的结构。Tedaniophorbasin A 具有新颖的 2-亚氨基-1,3-二甲基-2,3,7,8-四氢-1H-[1,4]噻嗪并[3,2-g]蝶啶-4(6)-酮骨架,而 tedaniophorbasin B 则是其 2-氧代衍生物。这些化合物在荧光光谱中表现出显著的斯托克斯位移(~14,000 cm),即在激发和发射波长之间。新化合物在 40 µM 时针对疟疾寄生虫氯喹敏感和氯喹耐药株、乳腺癌和胰腺癌细胞系以及原生动物寄生虫进行了生物活性测试,但对所有靶标均无活性。